Evotec advances psychiatric drug discovery through integrated neuroscience expertise, innovative technologies, and translational platforms. With over 30 years of experience, our end-to-end capabilities - spanning iPSC-derived cellular models, advanced electrophysiology, multiomics analytics, and predictive in vivo systems - enable the discovery and development of next-generation treatments for psychiatric disorders including depression, anxiety, bipolar disorder, schizophrenia, and autism. Combining scientific rigor with translational insight, Evotec de-risks programs and accelerates the path from discovery to clinical success.